<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content
www.championsoncology.comhs-fshubfsChampions_Logo_New_White-2


Access the Latest Data from AACR26

Stay up to date with the hottest preclinical data this year!

 

Our Latest Oncology Solutions

Our team presented 8 novel research posters at the AACR26 annual meeting.

Discover how our innovative oncology services can support your discovery, research and development. 

 

Poster #1884
Molecular determinants of sensitivity and resistance to the pan-RAS(ON) inhibitor daraxonrasib (RMC-6236) across KRAS-mutant patient-derived models 

Poster #2832
Evaluation of Natural Killer cells’ Contribution to the Efficacy of Immuno-oncology Regimens in Patient Derived Xenograft-Derived 3D Models 

Poster #4868
Modelling glioblastoma sensitivity to irradiation with a patient derived xenograft-derived 3D platform 

Poster #5812
Preclinical evaluation of [177Lu] Lu-PSMA-617 and [225Ac] Ac-PSMA-617 in mice bearing castration-resistant prostate adenocarcinoma patient-derived xenografts 

Poster #6415
Scalable chem-seq and functional-seq platforms for profiling chemical and genetic perturbations in patient-derived organoids 

Poster #7174
CAR T-Cell therapy efficacy evaluation in TumorGraft3D tri-culture platform with reconstructed tumor microenvironment 

Poster #7213
Evaluation of folate receptor-alpha antibody-drug conjugate mirvetuximab soravtansine-gynx in ovarian cancer PDXs 

Poster #7214
LymphGen-Based Stratification of DLBCL PDX Models Mirrors Clinical Tumor Complexity